Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.034 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |